WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Ownership - Who owns Compass Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Compass Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas J. SchuetzCHIEF EXECUTIVE OFFICER2025-05-2710,000$2.11
$21.10kBuy
Carl L. GordonDirector2025-04-093,571,428$1.59
$5.68MSell
Orbimed Advisors LLCDirector2025-04-093,571,428$1.59
$5.68MSell
Neil LernerCHIEF ACCOUNTING OFFICER2025-04-0720,000$1.42
$28.40kBuy
Jonathan AndermanGen Counsel Corporate Sec2025-04-0720,000$1.54
$30.80kBuy
Thomas J. SchuetzCEO2025-02-0841,687$3.50
$145.90kSell
Thomas J. SchuetzCEO2025-01-0958,054$1.86
$107.98kSell
Barry ShinCFO2024-12-09400,000$1.65
$660.00kBuy

1 of 1

CMPX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CMPX insiders and whales buy or sell their stock.

CMPX Shareholders

What type of owners hold Compass Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carl L. Gordon11.01%15,219,994$56.92MInsider
Orbimed Advisors LLC11.01%15,219,994$56.92MInstitution
Orbimed Advisors LLC11.01%15,219,994$56.92MInsider
Tang Capital Management LLC9.76%13,496,208$50.48MInstitution
Blackstone Inc7.25%10,025,151$37.49MInstitution
Enavate Sciences GP LLC5.63%7,788,150$29.13MInstitution
Suvretta Capital Management LLC5.17%7,149,493$26.74MInstitution
Thomas J. Schuetz4.69%6,480,825$24.24MInsider
Blackrock Inc4.64%6,413,133$23.99MInstitution
Vivo Capital LLC4.37%6,043,466$22.60MInstitution

1 of 3

CMPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMPX72.63%27.37%Net Selling
VSTM51.47%48.53%Net SellingNet Selling
CGEM56.12%43.88%Net BuyingNet Buying
MNPR14.23%85.77%Net SellingNet Selling
ADCT60.40%38.28%Net Buying
View Top Biotech Stocks

Compass Therapeutics Stock Ownership FAQ

Who owns Compass Therapeutics?

Compass Therapeutics (NASDAQ: CMPX) is owned by 78.28% institutional shareholders, 29.49% Compass Therapeutics insiders, and 0.00% retail investors. Carl L. Gordon is the largest individual Compass Therapeutics shareholder, owning 15.22M shares representing 11.01% of the company. Carl L. Gordon's Compass Therapeutics shares are currently valued at $56.92M.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.